HUMIRA
- Name: HUMIRA
- Generic Name : Adalimumab
- Strength: 40 mg (0.8 mL) Injection.
- Manufactured: ABBOT LABS. INC. (ABBVIE).
Medical Uses
Humira (adalimumab injection) is a tumor necrosis factor (TNF) blocker used for treatment of:
Rheumatoid Arthritis (RA): Reducing signs and symptoms, inducing major clinical response, blocking the progression of structural damage, and improving physical function in adults with moderately to severely active disease.
Psoriatic Arthritis: Reducing signs/symptoms of active arthritis, inhibiting the progression of structural damage, and improving the physical function.
Ankylosing Spondylitis: Reducing signs and symptoms in patients with active disease.
Crohn’s Disease: Reducing signs/symptoms and inducing and maintaining the clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy. Reducing signs/symptoms and inducing clinical remission in these patients if they have also lost response to or are not tolerant to infliximab.
Plaque Psoriasis: The treatment of adult patients with moderate to severe chronic plaque psoriasis who are recipients for systemic therapy or phototherapy.
Warning & Precautions
- Treatment with adalimumab 40 mg should not be initiated in patients with active infections including chronic or localized infections.
- Patients who develop a new infection while undergoing treatment with the inj adalimumab 40 mg should be monitored closely. Discontinue therapy if a patient develops a serious infection.
- Prior to the initiation of therapy with humira 40 mg injection, patients should be assessed for tuberculosis risk factors and should be tested for latent tuberculosis infection.
- Prescribers must exercise the precise caution in considering humira uses in patients with preexisting/recent-onset central nervous system demyelinating disorders.
- Concurrent use of anakinra and other TNF-blockers was associated with a greater proportion of serious infections and neutropenia. Therefore, the combination of humira 40 mg and anakinra is not recommended.
- Humira therapy may result in the formation of autoantibodies and, rarely, in the development of a lupus-like syndrome. If symptoms develop, treatment with humira injection dosage should be discontinued.
Documentation & Availability
What documents are required to import HUMIRA to India?
HUMIRA Injection (Adalimumab) can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is HUMIRA available in India?
HUMIRA is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
HUMIRA can be made available in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune and other cities in India.
S S Healthcare can facilitate the supply of HUMIRA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91 9310090915- Toll Free – 18008891064 for humira injection price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the Humira Injection (Cancer Treatment Medicines) from across the globe, and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Humira® ?
Adalimumab is Generic Name for the trade name drug Humira®.
What is the Manufacturer Name of Humira®?
Humira® is manufactured by Abbott Labs Inc. (ABBVIE).
Is Humira® approved by the FDA?
Yes, Humira® is approved by the FDA. The product was approved in December 2002.
What is the dosage and form of Humira® available?
Humira is available as 1 mL prefilled glass syringe provides 40 mg (0.8 mL) Injection.
How is Humira (Adalimumab) vial supplied?
Each vial of Humira (Adalimumab) contains 40 mg (0.8 ml). The product is available as either a single-use, prefilled humira pen (HUMIRA Injection).
What are the storage conditions of Humira (Adalimumab)?
Humira (Adalimumab) must be refrigerated at 36°F to 46°F (2°C to 8°C). Do not freeze.
What are the Highlights of prescribing information for Humira®?
Click Here to download full humira prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
